Surgical Hemostats Market Analysis

 End-Users (Hospitals, Specialty Clinics, Ambulatory Surgical Centers)

The hospitals segment is expected to hold 50% share of the global surgical hemostats market by the end of 2037. The segment is flourishing as a result of the increasing integration of technology in healthcare practices. Modern hospitals are increasingly adopting advanced technologies such as robotic-assisted surgeries, image-guided interventions, and real-time monitoring systems.  Hospitals, as early adopters of these technologies, drive the demand for innovative surgical hemostats that complement and enhance these technological advancements. The integration of healthcare technologies is steadily increasing, with an annual growth rate of 15%.

Additionally, patient safety remains a paramount concern for hospitals, influencing the adoption of surgical hemostats. Effective hemostasis is a critical component of surgical care, with the potential to significantly reduce postoperative complications. Hospitals prioritize the use of hemostatic agents that contribute to positive patient outcomes by minimizing complications related to bleeding.

Formulation (Matrix & Gel, Sponge, Sheet & Pad, Powder)

The sheet & pad segment in the surgical hemostats market is set to garner a notable share shortly. Hemostat pads and sheets are multilayered materials with a self-adhering surface with a backing that resembles a sheet and are often used to regulate bleeding associated with surgery. 

In addition, a hemostatic sponge promotes tissue regeneration and has antibacterial and absorbent qualities, which have been utilized in dermatologic surgery to manage postoperative hemostasis resulting from low-pressure arteriolar, venous, and capillary bleeding.

Our in-depth analysis of the surgical hemostats market includes the following segments: